MedPath

回音必集团浙江齐齐制药有限公司

Ownership
-
Established
2015-12-28
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

NMPA:23

Drug Approvals

Cefaclor Capsules

Product Name
头孢克洛胶囊
Approval Number
国药准字H20094037
Approval Date
Aug 3, 2024
NMPA

孕康口服液

Approval Number
国药准字Z10970068
Approval Date
May 22, 2020
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H33021333
Approval Date
May 22, 2020
NMPA

Roxithromycin Tablets

Product Name
罗红霉素片
Approval Number
国药准字H20045078
Approval Date
May 22, 2020
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H33021331
Approval Date
May 22, 2020
NMPA

Ciprofloxacin Hydrochloride Capsules

Product Name
盐酸环丙沙星胶囊
Approval Number
国药准字H33022300
Approval Date
Apr 30, 2020
NMPA

Ciprofloxacin Hydrochloride Tablets

Product Name
盐酸环丙沙星片
Approval Number
国药准字H33022262
Approval Date
Apr 30, 2020
NMPA

Nimodipine Capsules

Product Name
尼莫地平胶囊
Approval Number
国药准字H33022109
Approval Date
Apr 30, 2020
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H33021332
Approval Date
Apr 30, 2020
NMPA

六味地黄胶囊

Approval Number
国药准字Z33020492
Approval Date
Apr 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.